🇺🇸 FDA
Patent

US 7371364

Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy

granted A61KA61K49/0032A61K49/0034

Quick answer

US patent 7371364 (Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy) held by The Board of Regents of the University of Texas System expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K49/0032, A61K49/0034, A61K49/0056, A61K51/08